Top

InhaleRx Ltd (ASX: IRX) (‘InhaleRx’ ‘IRX’ or ‘the Company’), an Australian healthcare company developing unique drug-device

Unico Silver Limited (“USL” or the “Company”) refers to the announcement on 20 August 2024 regarding

S&P 500 and Nasdaq: New Targets and Support Levels During this morning’s Asian trading session, the S&P

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive

S&P 500 and Nasdaq: New Targets and Support Levels During this morning’s Asian trading session, the S&P

Loading